These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 24316488)

  • 21. A genetic variant in pre-miR-27a is associated with a reduced breast cancer risk in younger Chinese population.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Jiang L; Ma T; Yang Q
    Gene; 2013 Oct; 529(1):125-30. PubMed ID: 23954879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with breast cancer susceptibility and prognosis.
    Li X; Kong X; Jiang L; Ma T; Yan S; Yuan C; Yang Q
    Cell Physiol Biochem; 2014; 33(1):165-72. PubMed ID: 24481145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.
    Bayram S; Sümbül AT; Dadaş E
    Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
    Lin Y; Nie Y; Zhao J; Chen X; Ye M; Li Y; Du Y; Cao J; Shen B; Li Y
    Carcinogenesis; 2012 Dec; 33(12):2377-83. PubMed ID: 22971574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlations of
    Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer.
    Krupa R; Sliwinski T; Morawiec Z; Pawlowska E; Zadrozny M; Blasiak J
    Exp Oncol; 2009 Dec; 31(4):250-1. PubMed ID: 20010525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
    Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
    Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of interleukin-10 gene variation with breast cancer prognosis.
    Gerger A; Renner W; Langsenlehner T; Hofmann G; Knechtel G; Szkandera J; Samonigg H; Krippl P; Langsenlehner U
    Breast Cancer Res Treat; 2010 Feb; 119(3):701-5. PubMed ID: 19437115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significant association of caveolin-1 (CAV1) genotypes with breast cancer in Taiwan.
    Liu LC; Su CH; Wang HC; Tsai CW; Chang WS; Ho CY; Wu CI; Li FJ; Lin CH; Lane HY; Bau DT
    Anticancer Res; 2011 Oct; 31(10):3511-5. PubMed ID: 21965771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.
    Anders CK; Hsu DS; Broadwater G; Acharya CR; Foekens JA; Zhang Y; Wang Y; Marcom PK; Marks JR; Febbo PG; Nevins JR; Potti A; Blackwell KL
    J Clin Oncol; 2008 Jul; 26(20):3324-30. PubMed ID: 18612148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCND1 and CDKN1B polymorphisms and risk of breast cancer.
    Canbay E; Eraltan IY; Cercel A; Isbir T; Gazioglu E; Aydogan F; Cacina C; Cengiz A; Ferahman M; Zengin E; Unal H
    Anticancer Res; 2010 Jul; 30(7):3093-8. PubMed ID: 20683061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
    Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P
    Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer.
    Ozgöz A; Samli H; Oztürk KH; Orhan B; Icduygu FM; Aktepe F; Imirzalioglu N
    J Cancer Res Ther; 2013; 9(3):370-5. PubMed ID: 24125968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of prognostic value of polymorphisms within estrogen metabolizing genes in Lithuanian breast cancer patients.
    Savukaitytė A; Ugenskienė R; Jankauskaitė R; Čereškevičius D; Šepetauskienė E; Juozaitytė E
    BMC Med Genet; 2015 Feb; 16():2. PubMed ID: 25648141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
    Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
    Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCL22 16C/a genetic variation is not associated with breast carcinoma in Southern Iranian population.
    Erfani N; Moghaddasi-Sani F; Razmkhah M; Haghshenas MR; Talei A; Ghaderi A
    Iran J Immunol; 2012 Dec; 9(4):226-33. PubMed ID: 23268288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
    Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
    Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
    Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
    Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.